Your browser doesn't support javascript.
loading
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy.
Cuypers, Lize; Vrancken, Bram; Fabeni, Lavinia; Marascio, Nadia; Cento, Valeria; Di Maio, Velia Chiara; Aragri, Marianna; Pineda-Peña, Andrea Clemencia; Schrooten, Yoeri; Van Laethem, Kristel; Balog, Daniel; Focà, Alfredo; Torti, Carlo; Nevens, Frederik; Perno, Carlo Federico; Vandamme, Anne-Mieke; Ceccherini-Silberstein, Francesca.
Afiliação
  • Cuypers L; KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Herestraat 49 - box 1040, 3000, Leuven, Belgium. lize.cuypers@kuleuven.be.
  • Vrancken B; KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Herestraat 49 - box 1040, 3000, Leuven, Belgium.
  • Fabeni L; National Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
  • Marascio N; KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Herestraat 49 - box 1040, 3000, Leuven, Belgium.
  • Cento V; Department of Health Sciences, Institute of Microbiology, School of Medicine, University of "Magna Graecia", Viale Europa, Germaneto, 88100, Catanzaro, Italy.
  • Di Maio VC; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Aragri M; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Pineda-Peña AC; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Schrooten Y; Global Health and Tropical Medicine, GHTM, Institute for Hygiene and Tropical Medicine, IHMT, University Nova de Lisboa, UNL, Rua da Junqueira 100, 1349-008, Lisbon, Portugal.
  • Van Laethem K; Molecular Biology and Immunology Department, Fundación Instituto de Immunología de Colombia (FIDIC), Basic Sciences Department, Universidad del Rosario, Bogotá, Colombia.
  • Balog D; KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Herestraat 49 - box 1040, 3000, Leuven, Belgium.
  • Focà A; KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Herestraat 49 - box 1040, 3000, Leuven, Belgium.
  • Torti C; Luciad, Computer Software, Gaston Geenslaan 11, 3001, Heverlee, Belgium.
  • Nevens F; Department of Health Sciences, Institute of Microbiology, School of Medicine, University of "Magna Graecia", Viale Europa, Germaneto, 88100, Catanzaro, Italy.
  • Perno CF; Department of Medical and Surgical Sciences, Unit of Infectious and Tropical Diseases, School of Medicine, University of "Magna Graecia", Viale Europa, Germaneto, 88100, Catanzaro, Italy.
  • Vandamme AM; KU Leuven - University of Leuven, Department of Clinical and Experimental Medicine, Hepatology, Leuven, Belgium.
  • Ceccherini-Silberstein F; University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium.
BMC Evol Biol ; 17(1): 70, 2017 03 07.
Article em En | MEDLINE | ID: mdl-28270091
ABSTRACT

BACKGROUND:

In-depth phylogeographic analysis can reveal migration patterns relevant for public health planning. Here, as a model, we focused on the provenance, in the current Italian HCV subtype 1a epidemic, of the NS3 resistance-associated variant (RAV) Q80K, known to interfere with the action of NS3/4A protease inhibitor simeprevir. HCV1a migration patterns were analysed using Bayesian phylodynamic tools, capitalising on newly generated and publicly available time and geo-referenced NS3 encoding virus genetic sequence data.

RESULTS:

Our results showed that both immigration and local circulation fuel the current Italian HCV1a epidemic. The United States and European continental lineages dominate import into Italy, with the latter taking the lead from the 1970s onwards. Since similar migration patterns were found for Q80K and other lineages, no clear differentiation of the risk for failing simeprevir can be made between patients based on their migration and travel history. Importantly, since HCV only occasionally recombines, these results are readily transferable to the genetic sequencing policy concerning NS5A RAVs.

CONCLUSIONS:

The patient migration and travel history cannot be used to target only part of the HCV1a infected population for drug resistance testing before start of antiviral therapy. Consequently, it may be cost-effective to expand genotyping efforts to all HCV1a infected patients eligible for simeprevir-based therapies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article